Zobrazeno 1 - 2
of 2
pro vyhledávání: '"B Eyck"'
Autor:
H Overtoom, B Eyck, B Van Der Wilk, B Noordman, P Van Der Sluis, B Wijnhoven, J Van Lanschot, S Lagarde
Publikováno v:
Diseases of the Esophagus. 35
Background and aim Standard treatment for locally advanced oesophageal cancer is neoadjuvant chemoradiotherapy (nCRT) plus surgery. Time to surgery (TTS) after nCRT seems safe up to 12 weeks and delaying surgery may improve patient condition and path
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d35a91c24dbc6acf829a9d03edbd0c8d
https://doi.org/10.1093/dote/doac015.045
https://doi.org/10.1093/dote/doac015.045
Autor:
B Eyck, J Lanschot, M Hulshof, B Wilk, J Shapiro, P Hagen, D Nieboer, M Berge Henegouwen, B Wijnhoven, H Laarhoven, G Nieuwenhuijzen, G Hospers, J Bonenkamp, M Cuesta, R Blaisse, O Busch, F Kate, G Creemers, C Punt, J Plukker, H Verheul, E Spillenaar Bilgen, H Dekken, M Sangen, T Rozema, K Biermann, J Beukema, A Piet, C Rij, J Reinders, H Tilanus, A Gaast
Publikováno v:
Diseases of the Esophagus. 33
Neoadjuvant chemoradiotherapy according to the Dutch randomised controlled ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS) has become standard of care for patients with cancer of the oesophagus or oesophagogastric junction.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a392a937ed08f899e2810596d61ab4d9
https://doi.org/10.1093/dote/doaa087.56
https://doi.org/10.1093/dote/doaa087.56